Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer

PaperCitations, authors & open-access status

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 32 citations, 2015 year and closed oa status.

32
Citations
2015
Year
closed
OA Status

Related on ScholarIQ

Bruce C. M. Wang
Author
Value in Health
Journal
HER2/EGFR in Cancer Research
Topic
HER2/EGFR in Cancer Research
Topic
Economic and Financial Impacts of Cancer
Topic
Biosimilars and Bioanalytical Methods
Topic
470M+ articles · free account